FIELD: chemistry, medicine.
SUBSTANCE: present invention relates to a new pyrimidine derivative. New pyrimidine derivative is represented by chemical formula 1, or a pharmaceutically acceptable salt thereof, where X and Y each independently appear as carbon or nitrogen, Z represents oxygen or C1-C4 alkyl group, R1 is C1-C4 alkyl group, C3-C6 cycloalkyl group, CF3 or dimethylamino group, R2 represents C1-C4 alkyl group, R3 is hydrogen or halogen group, R4 represents hydrogen, halogen group, CN, CF3, C1-C4 alkyl group or aminocarbonyl group, R5 appears as hydrogen or C1-C4 alkyl group a group, R6 is C1-C4 alkyl group, R7 presents hydrogen, amino group substituted with one or more C1-C4 alkyl groups, or piperazinyl group, unsubstituted or substituted with one or more C1-C4 alkyl groups, when Z is oxygen, Z forms a double bond with S, which forms a single bond with N, or when Z represents C1-C4 alkyl group, Z forms a single bond with S, which generates a double bond with N; and R4 and R5 can also be bonded to form pyrrole, imidazole or thiophene. The invention also relates to the pharmaceutical composition for lung cancer treatment and containing an effective amount of the compound represented by Formula 1 or pharmaceutically acceptable salt thereof.
EFFECT: new pyrimidine derivative is obtained and described, which effectively inhibits the growth of cancer cells with the expression of C797S-mutant EGFR and MET-amplification, which are the main mechanisms of resistance to third-generation anti-cancer drugs targeting EGFR, and thus can be effectively used for lung cancer treatment.
Formula I
7 cl, 2 tbl, 18 ex
Title | Year | Author | Number |
---|---|---|---|
NEW PYRIMIDINE DERIVATIVE SUBSTITUTED WITH DEUTERIUM AND PHARMACEUTICAL COMPOSITION CONTAINING IT | 2020 |
|
RU2811770C1 |
PYRIMIDINE DERIVATIVE THAT SUPPRESSES CANCER CELL GROWTH AND MEDICAL APPLICATION THEREOF | 2020 |
|
RU2792849C1 |
COMPOUNDS AND A COMPOSITION FOR MODULATING THE KINASE ACTIVITY OF EGFR MUTANTS | 2015 |
|
RU2727700C2 |
DIAMINOPYRIMIDINE DERIVATIVES AND METHODS FOR PRODUCTION THEREOF | 2012 |
|
RU2587981C2 |
NOVEL FUSED PYRIMIDINE DERIVATIVES FOR INHIBITION OF TYROSINE KINASE ACTIVITY | 2011 |
|
RU2585177C2 |
PYRROLO-PYRIDINE COMPOUND DERIVATIVE, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING AND TREATING PROTEIN KINASE RELATED DISEASES | 2018 |
|
RU2730849C1 |
NEW CATECHOL DERIVATIVES OR THEIR SALT, METHODS OF THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2019 |
|
RU2795227C2 |
1,3,4-OXADIAZOLE SULPHONAMIDE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS 6 AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF | 2016 |
|
RU2697665C1 |
COMPOUNDS AND COMPOSITIONS FOR MODULATING KINASE ACTIVITY OF EGFR MUTANTS | 2015 |
|
RU2822389C2 |
NEW COMPOUND, METHOD OF ITS PREPARATION AND USE | 2021 |
|
RU2814103C1 |
Authors
Dates
2021-03-03—Published
2018-12-06—Filed